Christoph Thorns Selected Research

Christoph Thorns Research Topics

Disease

30	Neoplasms (Cancer) 12/2021 - 04/2002
12	Lymphoma (Lymphomas) 01/2019 - 07/2002
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 03/2007
5	Neoplasm Metastasis (Metastasis) 06/2019 - 09/2014
4	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 02/2013
4	Adenocarcinoma 01/2019 - 10/2009
3	Obesity 01/2022 - 08/2015
3	Carcinoma (Carcinomatosis) 06/2019 - 02/2003
3	Carcinogenesis 08/2017 - 04/2002
3	Multiple Myeloma 02/2017 - 01/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2014 - 09/2008
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2002 - 04/2002
2	Insulin Resistance 01/2022 - 08/2015
2	Genomic Instability 12/2021 - 07/2019
2	Aneuploidy (Aneuploid) 07/2019 - 12/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2018 - 03/2016
2	Erdheim-Chester Disease 03/2018 - 10/2015
2	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 01/2017 - 01/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2016 - 10/2009
2	Body Weight (Weight, Body) 01/2016 - 08/2015
2	Weight Gain 01/2016 - 08/2015
2	Squamous Cell Carcinoma of Head and Neck 03/2015 - 10/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2014 - 09/2008
2	Esophageal Neoplasms (Esophageal Cancer) 09/2014 - 08/2014
2	Hodgkin Disease (Hodgkin's Disease) 09/2002 - 07/2002
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Ulcerative Colitis 08/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Amenorrhea 01/2017
1	Atherosclerosis 11/2016
1	Weight Loss (Weight Reduction) 08/2015
1	Bone Diseases (Bone Disease) 06/2015
1	Osteosarcoma (Osteogenic Sarcoma) 06/2015
1	Lymphadenitis (Adenitis) 04/2015
1	Hyperplasia 04/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 04/2015
1	Autoimmune Diseases (Autoimmune Disease) 04/2015
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2015
1	Gonadal Dysgenesis (Gonadal Agenesis) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Oropharyngeal Neoplasms 10/2014
1	Prostatic Neoplasms (Prostate Cancer) 10/2014

Drug/Important Bio-Agent (IBA)

9	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2008
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2003
5	Hemoglobins (Hemoglobin)IBA 03/2015 - 10/2011
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2014
4	ParaffinIBA 02/2017 - 10/2009
3	Telmisartan (Micardis)FDA Link 01/2022 - 08/2015
3	Angiotensin IIIBA 01/2022 - 09/2005
3	Formaldehyde (Formol)FDA Link 02/2017 - 01/2011
2	LeptinIBA 01/2022 - 08/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2017 - 10/2016
2	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 01/2016
2	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2004 - 07/2002
2	Complementary DNA (cDNA)IBA 09/2002 - 04/2002
1	Phenobarbital (Luminal)FDA Link 07/2021
1	Hematoxylin (Haematoxylon)IBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2020
1	Immunomodulating AgentsIBA 10/2019
1	Peptides (Polypeptides)IBA 07/2019
1	Calcibiotic Root Canal SealerIBA 07/2019
1	Therapeutic UsesIBA 01/2019
1	Antinuclear AntibodiesIBA 03/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Testosterone (Sustanon)FDA Link 01/2017
1	hydrogen sulfite (bisulfite)IBA 01/2017
1	AntibodiesIBA 10/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2016
1	somatostatin receptor 2IBA 03/2016
1	Estrogens (Estrogen)FDA Link 03/2016
1	Estrogen ReceptorsIBA 03/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2016
1	thymosin beta(4)IBA 12/2015
1	VemurafenibIBA 10/2015
1	canakinumab FDA Link 10/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2015
1	Type 1 Angiotensin ReceptorIBA 08/2015
1	angiotensin I (1-7)IBA 08/2015
1	Carrier Proteins (Binding Protein)IBA 06/2015
1	Cathepsin DIBA 06/2015
1	AndrogensIBA 01/2015
1	inhibin BIBA 01/2015
1	Hormones (Hormone)IBA 01/2015
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2014
1	Genetic Markers (Genetic Marker)IBA 10/2014

Therapy/Procedure

10	Therapeutics 04/2020 - 04/2002
4	Drug Therapy (Chemotherapy) 03/2015 - 10/2011
2	Prostatectomy (Retropubic Prostatectomy) 12/2021 - 10/2014
2	Neoadjuvant Therapy 06/2019 - 01/2019
2	Precision Medicine 01/2017 - 06/2015
2	Radiotherapy 03/2015 - 08/2014
1	Time-to-Treatment 01/2018
1	Aftercare (After-Treatment) 01/2016
1	Colectomy 06/2015
1	Restorative Proctocolectomy 06/2015
1	Chemoradiotherapy 10/2014